Quinoline and quinolones: promising scaffolds for future antimycobacterial agents

References

• World Health Organization (WHO). Available from: http://www.who.int/mediacentre/factsheets/fs104/en/index.html [last accessed May 6 2013]
   Google Scholar
• Engohang-Ndong J. Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment. Expert Opin Investig Drugs 2012;12:1789–800
   Google Scholar
• Andries K, Verhasselt P, Guillemont J, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005;5707:223–7
   Google Scholar
• Matteelli A, Carvalho AC, Dooley KE, Kritski A. TMC207: the first compound of a new class of potent anti-tuberculosis drugs. Future Microbiol 2010;5:849–58
   PubMed Web of Science ®Google Scholar
• Haagsma AC, Abdillahi-Ibrahim R, Wagner MJ, et al. Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue. Antimicrob Agents Chemother 2009;3:1290–2
   Google Scholar
• Ibrahim M, Andries K, Lounis N, et al. Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis. Antimicrob Agents Chemother 2007;51:1011–15
   PubMed Web of Science ®Google Scholar
• Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009;360:2397–405
   PubMed Web of Science ®Google Scholar
• Avorn J. Approval of a tuberculosis drug based on a paradoxical surrogate measure. JAMA 2013;309:1349–50
   PubMed Web of Science ®Google Scholar
• Adhvaryu M, Vakharia B. Drug-resistant tuberculosis: emerging treatment options. Clin Pharmacol 2011;3:51–67
   Google Scholar
• Mistry BM, Jauhari, S. Synthesis and in vitro antimicrobial and anti-tubercular evaluation of some quinoline-based azitidinone and thiazolidinone analogues. Med Chem Res 2013;22:635–46
   Web of Science ®Google Scholar
• Jain AK, Vaidya A, Ravichandran V, Kashaw SK. Recent developments and biological activities of thiazolidinone derivatives: a review. Bioorg Med Chem 2012;20:3378–95
   PubMed Web of Science ®Google Scholar
• Paul N, Murugavel M, Muthusubramanian S, Sriram D. Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents. Bioorg Med Chem Lett 2012;22:1643–8
   PubMed Web of Science ®Google Scholar
• Mungra DC, Patel MP, Rajani DP, Patel RG. Synthesis and identification of β-aryloxyquinolines and their pyrano[32-c] chromene derivatives as a new class of antimicrobial and antituberculosis agents. Eur J Med Chem 2011;46:4192–200
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Vandavasi JK, Vasireddy NR, et al. Design synthesis biological evaluate on and molecular modeling studies of novel quinoline derivatives against Mycobacterium tuberculosis. Bioorg Med Chem 2009;17:2830–41
   PubMed Web of Science ®Google Scholar
• Eswaran S, Adhikari AV, Kumar RA. New 13-oxazolo[45-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties. Eur J Med Chem 2010;45:3957–66
   Google Scholar
• Nayyar A, Monga V, Malde A, et al. Synthesis anti-tuberculosis activity and 3D-QSAR study of 4-adamantan-1-yl-2-substituted quinolines. Bioorg Med Chem 2007;15:626–40
   PubMed Web of Science ®Google Scholar
• Nayyar A, Patel SR, Shaikh M, et al. Synthesis anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-adamantan-1-yl group containing quinolines. Eur J Med Chem 2009;44:2017–29
   PubMed Web of Science ®Google Scholar
• Thomas KD, Adhikari AV, Telkar S, et al. Design synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur J Med Chem 2011;46:5283–92
   PubMed Web of Science ®Google Scholar
• Eswaran S, Adhikari AV, Pal NK, Chowdhury IH. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents. Bioorg Med Chem Lett 2010;20:1040–4
   PubMed Web of Science ®Google Scholar
• Thomas KD, Adhikari AV, Chowdhury IH, Sumesh E. New quinolin-4-yl-1 2 3-triazoles carrying amides sulphonamides and amidopiperazines as potential antitubercular agents. Eur J Med Chem 2011;46:2503–12
   PubMed Web of Science ®Google Scholar
• Thomas KD, Adhikari AV, Imran H, et al. Design synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties. Eur J Med Chem 2011;46:4834–45
   PubMed Web of Science ®Google Scholar
• Carmo AML, Silva FMC, Machado PA, Fontes APS. Synthesis of 4-aminoquinoline analogues and their platinum: II complexes as new antileishmanial and antitubercular agents. Biomed Pharmacother 2011;65:204–9
   PubMed Web of Science ®Google Scholar
• Candéa ALP, Ferreira MDL, Pais KC, et al. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg Med Chem Lett 2009;19:6272–4
   PubMed Web of Science ®Google Scholar
• De Souza MVN, Pais KC, Kaiser CR, Peralta MA. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem 2009;17:1474–80
   PubMed Web of Science ®Google Scholar
• Gemma S, Savini L, Altarelli M, et al. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure–activity relationship studies. Bioorg Med Chem 2009;17:6063–72
   PubMed Web of Science ®Google Scholar
• Sharma M, Chaturvedi V, Manju YK, et al. Substituted quinolinylchalcones and quinolinylpyrimidines as a new class of anti-infective agents. Eur J Med Chem 2009;44:2081–91
   PubMed Web of Science ®Google Scholar
• Parekh NM, Maheria KC. Antituberculosis and antibacterial evaluations of some novel phenyl pyrazolone-substituted 1h-benzo[g]pyrazolo[34-b]quinoline-3-ylamine derivatives. Med Chem Res 2012;21:4168–76
   Web of Science ®Google Scholar
• Karthikeyan SV, Perumal S, Shetty KA, et al. A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-34-dihydro-2H-thieno[32-b]indoles. Bioorg Med Chem Lett 2009;19:3006–9
   PubMed Web of Science ®Google Scholar
• Balamurugan K, Jeyachandran V, Perumal S, Manjashetty TH. A microwave-assisted facile regioselective Friedlander synthesis and antitubercular evaluation of 2,9-diaryl-2 3-dihydrothieno-[3 2-b]quinolines. Eur J Med Chem 2010;45:682–8
   PubMed Web of Science ®Google Scholar
• Kantevari S, Yempala T, Muthusubramanian S, Manisankar P. Synthesis and antitubercular evaluation of novel dibenzo[bd]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[32-c]quinolines via Povarov reaction. Eur J Med Chem 2011;46:4827–33
   PubMed Web of Science ®Google Scholar
• Gonçalves RSB, Kaiser CR, Lourenço MCS, De Souza MVN. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives. Eur J Med Chem 2010;45:6095–100
   PubMed Web of Science ®Google Scholar
• Chitra S, Paul N, Muthusubramanian S, et al. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies. Eur J Med Chem 2011;46:4897–903
   PubMed Web of Science ®Google Scholar
• Gonçalves RSB, Kaiser CR, Lourenço MCS, et al. Mefloquine–oxazolidine derivatives derived from mefloquine and arenecarbaldehydes: in vitro activity including against the multidrug-resistant tuberculosis strain T113. Bioorg Med Chem 2012;20:243–8
   PubMed Web of Science ®Google Scholar
• Eswaran S, Adhikari AV, Chowdhury I, et al. New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties. Eur J Med Chem 2010;45:3374–83
   PubMed Web of Science ®Google Scholar
• Senthilkumar P, Dinakaran M, Banerjee D, et al. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-14-dihydro-6-fluoro-7-:substituted secondary amino-8-methoxy-5-:sub-4-oxoquinoline-3-carboxylic acids. Bioorg Med Chem 2008;16:2558–69
   PubMed Web of Science ®Google Scholar
• Senthilkumar P, Dinakaran M, Yogeeswari P, et al. Antimycobacterial activities of novel fluoroquinolones. Biomed Pharmacother 2009;63:27–35
   PubMed Web of Science ®Google Scholar
• Senthilkumar P, Dinakaran M, Yogeeswari P, et al. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids. Eur J Med Chem 2009;44:345–58
   PubMed Web of Science ®Google Scholar
• Dinakaran M, Senthilkumar P, Yogeeswari P, et al. Antimycobacterial activities of novel 2-sub-3 fluoro/nitro-5 12-dihydro-5-oxobenzothiazolo [3-2a]quinoline-6-carboxylic acid. Bioorg Med Chem 2008;16:3408–18
   PubMed Web of Science ®Google Scholar
• Dinakaran M, Senthilkumar P, Yogeeswari P, et al. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation. Bioorg Med Chem Lett 2008;18:1229–36
   PubMed Web of Science ®Google Scholar
• Sriram D, Yogeeswari P, Basha JS, et al. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg Med Chem 2005;13:5774–8
   PubMed Web of Science ®Google Scholar
• Sriram D, Aubry A, Yogeeswari P, Fisher LM. Gatifloxacin derivatives: synthesis, antimycobacterial activities and inhibition of Mycobacterium tuberculosis DNA gyrase. Bioorg Med Chem Lett 2006;16:2982–5
   PubMed Web of Science ®Google Scholar
• Zhao YL, Chen YL, Sheu JY, et al. Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives. Bioorg Med Chem 2005;13:3921–6
   PubMed Web of Science ®Google Scholar
• Talath S, Gadad AK. Synthesis antibacterial and antitubercular activities of some7-[4-5-amino-[1, 3, 4] thiadiazole-2-sulfonyl-piperazin-1-yl] fluoroquinolonic derivatives. Eur J Med Chem 2006;41:918–24
   PubMed Web of Science ®Google Scholar
• Rikova EV, Polanc S, Kocevar M, et al. New fluorine-containing hydrazones active against MDR-tuberculosis. Eur J Med Chem 2011;46:4937–45
   PubMed Web of Science ®Google Scholar
• Barends M, Jaidee A, Khaohirun N, et al. In vitro activity of ferroquine:SSR 97193 against Plasmodium falciparum isolates from the Thai-Burmese border. Malar J 2007;27:81–5
   Google Scholar
• Mahajan A, Kremer L, Louw S, et al. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazons. Bioorg Med Chem Lett 2011;21:2866–8
   PubMed Web of Science ®Google Scholar
• Parmar NJ, Barad HA, Pansuriya BR, Teraiya SB. An efficient one-pot synthesis structure antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones. Bioorg Med Chem Lett 2012;22:3816–21
   PubMed Web of Science ®Google Scholar
• Manvar A, Bavishi A, Radadiya S, et al. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains. Bioorg Med Chem Lett 2011;21:4728–31
   PubMed Web of Science ®Google Scholar
• Carta A, Palomba M, Paglietti G, et al. [1,2,3]Triazolo[4,5-h]quinolones: a new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains. Bioorg Med Chem Lett 2007;17:4791–4
   PubMed Web of Science ®Google Scholar
• Carta A, Palomba M, Briguglio I, et al. Synthesis and anti-mycobacterial activities of triazoloquinolones. Eur J Med Chem 2011;46:320–6
   PubMed Web of Science ®Google Scholar
• Kantevari S, Patpi SR, Sridhar B, et al. Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones. Bioorg Med Chem Lett 2011;21:1214–17
   PubMed Web of Science ®Google Scholar
• Shah NM, Patel MP, Patel RG. New N-arylaminobiquinoline derivatives: synthesis, antimicrobial, antituberculosis and antimalarial evaluation. Eur J Med Chem 2012;54:239–47
   PubMed Web of Science ®Google Scholar